drugset / Trial / NCT01394185
Effects of Dronabinol (Oral THC) on Cannabis Use
Phase 1/2
Completed
25 enrolled
Johns Hopkins University
National Institute on Drug Abuse (NIDA) · collab
RandomizedSingle-groupDouble-blindBasic science
Summary
Study participants received dronabinol (0, 120mg/day and 240mg/day) for 12 consecutive days in a randomized order. During each dronabinol maintenance period they were able to self-administer active or placebo cannabis using either a progressive ratio schedule or choice between cannabis and monetary alternative.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dronabinol | Other / unclassified | 40 mg | Oral |
| Comparator | Dronabinol | Other / unclassified | 80 mg | Oral |
Indications
No indication recorded.